1.
The other 75 per cent of lung cancers consist of a variety of "non-small cell cancers".
其余75％的肺癌属于各种“非小细胞肺癌”。
2.
hsa-miR-125a-5p Enhances Invasion Ability in Non-Small Lung Carcinoma Cell Lines
hsa-miR-125a-5p促进非小细胞肺癌细胞侵袭
3.
Gifitinib in the Treatment for 22 Cases with Advanced Non-small Cell Lung Cancer
吉非替尼治疗22例晚期非小细胞肺癌
4.
The Study of CD44s Expression of Lung Cancer Cells and Peripheral Blood Lymphocytes in NSCLC;
非小细胞肺癌病人外周血淋巴细胞及肺癌细胞CD44s的表达研究
5.
Actuality of Radiotherapy for Local Advanced Non-small Cell Lung Cancer
局部晚期非小细胞肺癌放射治疗现状
6.
Study on the Polymorphisms of Genes Associated with Non-small-cell Lung Cancer;
非小细胞肺癌相关基因的多态性研究
7.
The Survival and Prognosis in Patients with N_1 Stage Non-small Cell Lung Cancer after Surgery;
N_1期非小细胞肺癌预后因素分析
8.
A Systematic Review of TCM in Treating Non-Small Cell Lung Cancer;
中医药治疗非小细胞肺癌的系统评价
9.
The Relationship between MTA1 and Metastasis and Prognosis and ER in Non-small Cell Lung Cancer;
MTA1与非小细胞肺癌转移、预后及ER关系
10.
The Expression of BAMBI in Non-small Cell Lung Cancer;
BAMBI在非小细胞肺癌中的表达
11.
Research of Iressa for Patients with Advanced NSCLC;
Iressa治疗晚期非小细胞肺癌的疗效观察
12.
～(18)F-FDG PET-CT for Detection of Non-Small Cell Lung Cancer;
～（18）F-FDG PET-CT评价非小细胞肺癌的价值
13.
Expression of PLK1 in NSCLC and Its Significance;
非小细胞肺癌组织PLK1的表达及其意义
14.
The Study of Multidrug Resistance and Its Reversal in Non Small Cell Lung Cancer;
非小细胞肺癌多药耐药及其逆转研究
15.
Expression of Bnip3L(Bcl-2/E1B 19kDa-interacting Protein 3-like) and Bcl-2 in Human Non-small Cell Lung Cancer.;
Bnip3L与Bcl-2在非小细胞肺癌中的表达
16.
Expression of PCNA、Ki-67 and P53 in Nonsmall Cell Lung Cancer;
非小细胞肺癌PCNA、ki-67和p53表达的研究
17.
Expression and Clinical Significance of Cathepsin D.CD. EGFR, in Non Smallcelllungcancer;
CD44V6、EGFR、CathD在非小细胞肺癌中的表达
18.
Vascular Invasion as Significant Prognostic Factor in Resected Nonsmall Cell Lung Carcinoma;
脉管瘤栓对非小细胞肺癌预后的影响